Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$12.78 - $17.4 $1,278 - $1,739
100 New
100 $1,000
Q1 2020

Apr 17, 2020

SELL
$6.69 - $13.45 $12,356 - $24,842
-1,847 Closed
0 $0
Q4 2019

Jan 21, 2020

BUY
$6.53 - $10.72 $11,101 - $18,224
1,700 Added 1156.46%
1,847 $18,000
Q3 2019

Oct 28, 2019

SELL
$6.16 - $9.6 $12,547 - $19,555
-2,037 Reduced 93.27%
147 $1,000
Q2 2019

Jul 12, 2019

BUY
$8.12 - $15.72 $12,561 - $24,318
1,547 Added 242.86%
2,184 $0
Q3 2018

Oct 04, 2018

SELL
$21.06 - $25.65 $2,106 - $2,565
-100 Reduced 13.57%
637 $0
Q2 2018

Jul 09, 2018

BUY
$16.77 - $24.71 $1,677 - $2,471
100 Added 15.7%
737 $0
Q4 2017

Jan 23, 2018

SELL
$11.23 - $19.1 $13,206 - $22,461
-1,176 Reduced 64.86%
637 $0
Q3 2017

Oct 17, 2017

BUY
$15.41 - $32.17 $27,938 - $58,324
1,813
1,813 $0

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Central Trust CO Portfolio

Follow Central Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Central Trust CO with notifications on news.